glp-1 and alcohol consumption Use Reduction: Can It Really Help? Frontiers | The therapeutic potential

Inflamm Bowel Dis 2024 Nov 27 [Epub]

10.1210/me.2014-1103 103 RosenstockJ.Aguilar-SalinasC.KleinE.NepalS.ListJ.ChenR.et al

J., Garlick, P

A 2024 systematic review and meta-analysis published in Obesity Reviews found that resistance exercise significantly attenuated lean mass loss during hypocaloric periods, with particularly pronounced effects when combined with adequate protein intake. The challenge is implementation

Obesity Drug Market Overview and Growth Potential The US obesity drug market is on a meteoric rise, projected to soar past USD 73 billion by 2034

Mechanism of action of GLP-1 receptor agonists: Direct receptor binding These medications bind specifically to GLP-1 receptors on pancreatic beta cells, stimulating insulin secretion in a glucose-dependent manner (meaning they work when blood glucose is elevated)